3 “Strong Buy” Healthcare Stocks That Should Remain Healthy
Dexamethasone: what is the breakthrough treatment for COVID-19?
3 "Strong Buy" Pharmaceutical Stocks With Major Catalysts Approaching
Kamada’s Covid-19 Therapy Approved For Compassionate Use In Israel
Royalty Pharma shares surge 59% after $2.2 billion IPO
Off-the-shelf tool for making mouse models of COVID-19
Exercise offers ‘profound’ benefits for Friedreich’s ataxia, research suggests
New COVID-19 Antibody Test Targets Unique Region of Spike Protein
Eli Lilly launches PhIII JAK study, aiming for the first drug to lower mortality in Covid-19
Dr Reddy’s Labs Signs Licensing Agreement For Gilead’s Remdesivir
Coronavirus shows how ageism is harmful to health of older adults
Startups Weekly: A Silicon Valley for everyone
Coronavirus pharma news roundup – 12/06/20
3 “Strong Buy” Penny Stocks With Massive Upside Ahead
UNC-Chapel Hill researchers create new type of COVID-19 antibody test
Lilly CSO: COVID-19 Antibody Treatment Could Be Ready by Fall 2020
HealthTunes unveils music therapy app for stressed COVID-19 fighters
Digital health predicted as the new normal in COVID aftermath
A drug for the treatment of COVID-19 complications is registered in Russia
Oxford Biomedica Clinches Manufacturing Deal For AstraZeneca’s Covid-19 Vaccine
Calliditas hits $90m jackpot as biotech IPO craze continues
AbbVie Announces Partnership To Develop Novel Covid-19 Antibody Therapy
Goldman Sachs: These 2 Stocks Are Poised to Surge by at Least 30%
Sorrento Therapeutics and Mount Sinai Health System
The mortgage industry’s united effort to combat COVID-19
Scientists aim gene-targeting breakthrough against COVID-19
3 “Strong Buy” Penny Stocks That Could See Outsized Returns
Compare the flu pandemic of 1918 and COVID-19 with caution – the past is not a prediction
Is The Stock Market’s Optimism For Economic Recovery Valid?
Coronavirus pharma news roundup – 04/06/20